Genetic factors associated with small for gestational age birth and the use of human growth hormone in treating the disorder
Open Access
- 15 May 2012
- journal article
- review article
- Published by Springer Nature in International Journal of Pediatric Endocrinology
- Vol. 2012 (1) , 12
Abstract
The term small for gestational age (SGA) refers to infants whose birth weights and/or lengths are at least two standard deviation (SD) units less than the mean for gestational age. This condition affects approximately 3%–10% of newborns. Causes for SGA birth include environmental factors, placental factors such as abnormal uteroplacental blood flow, and inherited genetic mutations. In the past two decades, an enhanced understanding of genetics has identified several potential causes for SGA. These include mutations that affect the growth hormone (GH)/insulin-like growth factor (IGF)-1 axis, including mutations in the IGF-1 gene and acid-labile subunit (ALS) deficiency. In addition, select polymorphisms observed in patients with SGA include those involved in genes associated with obesity, type 2 diabetes, hypertension, ischemic heart disease and deletion of exon 3 growth hormone receptor (d3-GHR) polymorphism. Uniparental disomy (UPD) and imprinting effects may also underlie some of the phenotypes observed in SGA individuals. The variety of genetic mutations associated with SGA births helps explain the diversity of phenotype characteristics, such as impaired motor or mental development, present in individuals with this disorder. Predicting the effectiveness of recombinant human GH (hGH) therapy for each type of mutation remains challenging. Factors affecting response to hGH therapy include the dose and method of hGH administration as well as the age of initiation of hGH therapy. This article reviews the results of these studies and summarizes the success of hGH therapy in treating this difficult and genetically heterogenous disorder.Keywords
This publication has 95 references indexed in Scilit:
- Lessons Learned from 15 Years of KIMS and 5 Years of ACROSTUDYHormone Research in Paediatrics, 2011
- Obesity and diabetes genes are associated with being born small for gestational age: Results from the Auckland Birthweight Collaborative studyBMC Medical Genetics, 2010
- Growth Hormone Treatment in Children is not Associated with an Increase in the Incidence of Cancer: Experience from KIGS (Pfizer International Growth Database)The Journal of Pediatrics, 2010
- Acid-Labile Subunit Deficiency and Growth Failure: Description of Two Novel CasesHormone Research in Paediatrics, 2010
- Methylation profiling in individuals with Russell–Silver syndromeAmerican Journal of Medical Genetics Part A, 2010
- The centromeric 11p15 imprinting centre is also involved in Silver–Russell syndromeJournal of Medical Genetics, 2006
- Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndromeNature Genetics, 2005
- A Randomized Controlled Trial of Three Years Growth Hormone and Gonadotropin-Releasing Hormone Agonist Treatment in Children with Idiopathic Short Stature and Intrauterine Growth RetardationThe Journal of Clinical Endocrinology & Metabolism, 2001
- Growth Hormone Treatment of Short Children Born Small for Gestational Age: Growth Responses with Continuous and Discontinuous Regimens Over 6 YearsThe Journal of Clinical Endocrinology & Metabolism, 2000
- Role of angiotensinogen in blood pressure homeostasis.Hypertension, 1982